COMPOSITION CONTAINING SCIRPUSIN A AND SCIRPUSIN B, AND ITS POTENTIAL AS ANTIOBESITY AGENT Russian patent published in 2019 - IPC A61K31/343 A61K36/8905 A61P3/04 A61P3/06 

Abstract RU 2691404 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: invention refers to pharmaceutical industry, namely to a composition for reducing obesity in humans, treating hypercholesterolemia in humans, achieving body weight reduction, body weight and waist circumference to maintain normal systemic lipid levels. Composition containing ethyl acetate fraction of methanol extract of Cyperus rotundus rhizomes, normalized to total content of stilbenes more than 3 %, for reduction of obesity in people. Composition containing ethyl acetate fraction of methanol extract of Cyperus rotundus rhizomes, normalized to total content of stilbenes more than 3 %, for treating hypercholesterinemia in humans. Use of the composition to achieve body weight reduction, body weight index and waist circumference. Use of the composition for maintaining normal systemic lipid levels by achieving effects (a) reducing systemic levels of total cholesterol, low-density lipoproteins (LDL), very low-density lipoproteins (VLDL) and serum triglycerides and (b) high systemic levels of high-density lipoproteins (HDL).

EFFECT: compositions described above are effective for reducing obesity in humans, treating hypercholesterolemia in humans, achieving body weight reduction, body weight and waist circumference to maintain normal systemic lipid levels.

10 cl, 18 tbl

Similar patents RU2691404C2

Title Year Author Number
CALEBIN A FOR HEPATIC STEATOSIS 2015
  • Nagabkhushanam Kalyanam
  • Madzhid Andzhu
  • Madzhid Mukhammed
RU2643297C2
COMPOSITION FOR ALLEVIATING, PREVENTING, OR TREATING BONE DISEASES OR METABOLIC DISEASES, CONTAINING A NEW STRAIN OF LACTOBACILLUS SAKEI CVL-001 AND A CULTURE MEDIUM THEREOF 2020
  • Park, Chon Khvan
  • Tsoj, Chu Khi
  • Chon, To Khen
RU2782361C1
DAIRY PRODUCT WITH REDUCED CHOLESTEROL CONTENT FOR APPLICATION AS MEDICATION 2010
  • Dalemans Daniel'
RU2546283C2
BETA-LACTAM COMPOUNDS OR THEIR SALTS FOR USE IN LONG-TERM PREVENTION OR TREATMENT OF DISORDERS OF GLUCOSE METABOLISM 2020
  • Li, Fen Lin
  • Lin, Lun Dzhejer.
  • Syuj, Dzhikh Shing
  • Syuj, Chen Syan
  • Khuan, Jen Chun
  • Khuan, Ya Chien
  • Lo, Chun Tszun
  • Lyao, Khuej Fan
  • Lyu, Yuj Ven
  • Kao, Yuj Chi
RU2811476C2
COMPOSITION FOR STIMULATING OSTEOGENESIS AND MAINTAINING THE HEALTH OF BONES 2002
  • Offord-Kejvin Ehlizabet
  • Federichi Ehrmanno
  • Lemor Bernar
  • Kurtua Did'E
RU2314717C2
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS 2019
  • Kim, Tsze-Sun
  • Ryu, Khyun-Chul
  • Lim, Tszi-Vun
  • Tszun, Tszyun-Gun
  • Kim, Sun-Zhu
  • Son, En-Vu
  • Kim, Khun-Tszyun
  • Son, Venlin
RU2765101C1
FODDER COMPOSITION FOR CONTROLLING BODY WEIGHT AND PREVENTING OBESITY AND OBESITY-ACCOMPANYING DISEASES IN DOMESTIC ANIMALS 2002
  • Lemor Bernar
  • Darimon-Nikolau Krist'Jan
RU2313228C2
HEPATOPROTECTIVE AGENT 2003
  • Fedoreev S.A.
  • Muzarok T.I.
  • Veselova M.V.
  • Pokushalova T.V.
  • Seletskaja L.D.
  • Bulgakov V.P.
  • Kulesh N.I.
  • Glebko L.I.
  • Chuchalin V.S.
  • Saratikov A.S.
  • Zhuravlev Ju.N.
RU2244553C1
PEPTIDE WITH ANTI-OBESITY AND ANTIDIABETIC EFFICACY AND USE THEREOF 2017
  • Chung, Yong Ji
  • Kim, Eun Mi
RU2721426C1
ADIPOSITY RISK REDUCTION 2010
  • Mas Katrin
  • Aprik'Jan Oliv'E
RU2559646C2

RU 2 691 404 C2

Authors

Madzhid Mukhammed

Nagabkhushanam Kalyanam

Kelman Duglas

Bkhat Beena

Vajdyanatkhan Priti

Bani Sarang

Pandej Andzhali

Karri Suresh

Dates

2019-06-13Published

2015-12-14Filed